ADIPOQ and Insulin resistance: As we have already mentioned, the development of insulin resistance in patients with obesity is related to adipokine dysregulation secondary to adipocyte hypertrophy and dysfunction, which leads to a decrease in insulin-sensitizing molecules such as adiponectin, and to an increase in pro-inflammatory cytokines [37,38,90].